Yellow Fever Vaccine for Indian Travellers: Countries, Yellow Card, 10-Day Rule & Contraindications
Planning a trip from India to Africa or South America? Yellow fever vaccination may be an important part of your travel preparation, but the rules are often misund Does every traveller to Africa need the vaccine? Which countries are considered yellow-fever endemic? How early should you get vaccinated? Is the Yellow Fever Vaccination Certificate valid for 10 years or for life? And what happens if you return to India without a valid certificate? For Indian travellers, there are actually three separate questions: Is there a risk of yellow fever at your destination? Does the destination country require a vaccination certificate? And will India require a valid certificate when you return? These questions do not always have the same answer. What is yellow fever? Yellow fever is a mosquito-borne viral infection found mainly in parts of sub-Saharan Africa and tropical Central and South America. Many infections are mild, but severe yellow fever can cause high fever, jaundice, bleeding, shock and multi-organ failure. There is no specific antiviral treatment. Fortunately, yellow fever is highly vaccine-preventable. A single dose of an approved yellow fever vaccine provides long-lasting protection for most travellers. Under the International Health Regulations (IHR), the related international vaccination certificate is valid for the lifetime of the vaccinated person. Which countries are relevant for Indian travellers? The Government of India currently lists 42 yellow-fever-endemic countries: 29 in Africa and 13 in Central and South America. The country list displayed on the Government of India International Health Regulations portal is identified as having been updated on 3 January 2023. Africa Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Sudan, South Sudan, Togo and Uganda. Central and South America Argentina, Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay, Peru, Suriname, Trinidad and Tobago, and Venezuela. However, an important distinction is necessary. Being on a yellow-fever-risk or endemic-country list does not automatically mean that vaccination is medically recommended for every traveller to every part of that country. Similarly, some countries without significant local yellow fever transmission may require proof of vaccination if you have recently travelled through a yellow-fever-risk country. Your exact itinerary, including transit airports and regions visited within a country, therefore matters. What is the Yellow Fever Certificate or “Yellow Card”? After vaccination at an authorised yellow fever vaccination centre, travellers receive an International Certificate of Vaccination or Prophylaxis (ICVP), commonly called the Yellow Card. For someone receiving yellow fever vaccine for the first time, the certificate becomes valid 10 days after vaccination. The important point is that the certificate is now valid for life. The previous international rule requiring a booster every 10 years was changed under the International Health Regulations. Therefore: First vaccination → certificate valid after 10 days → certificate remains valid for life. Although the international certificate is valid for life, additional vaccine doses may occasionally be considered for selected individuals or particular exposure situations on medical grounds. That is different from requiring a routine booster simply to keep the Yellow Card valid. When should you take the yellow fever vaccine? The minimum requirement is straightforward: Get vaccinated at least 10 days before the certificate is required. Vaccination immediately before boarding your flight does not provide an immediately valid certificate. Practically, however, travellers should ideally arrange a Pre-travel consulation several weeks before departure. This gives enough time to assess other vaccines, Malaria prevention, medical conditions and destination-specific health risks. If another live viral vaccine such as MMR is required, yellow fever vaccine can generally be given on the same day. If the vaccines are not administered simultaneously, a gap of about 4 weeks is generally used between live vaccines. What happens when returning to India? This is particularly important for Indian travellers. Government of India guidance states that international travellers arriving in India within six days of departure from a yellow-fever-endemic country must possess the original valid Yellow Fever Vaccination Certificate. A traveller arriving without a valid original certificate can be quarantined until the certificate becomes valid or until six days have elapsed since the last possible exposure, whichever occurs earlier. A certificate may also be considered invalid if important details are incomplete or incorrect, the vaccine was given at a non-designated centre, necessary signatures or stamps are missing, or the traveller carries only a photocopy or digital copy instead of the required original certificate. Keep your original Yellow Card with your passport while travelling. Does an airport transit or layover count? Sometimes. A traveller may assume that yellow fever vaccination is irrelevant because the yellow-fever-risk country is only a transit point. That assumption can cause problems. The Government of India advises that passengers transiting through a yellow-fever-endemic country who leave the airport transit area should possess a valid Yellow Fever Vaccination Certificate. Other countries may have their own rules based on the transit country and duration of the layover. Therefore, yellow fever requirements should be checked using your entire flight itinerary, not simply your final destination. Who should not receive yellow fever vaccine? Yellow fever vaccine is a live attenuated vaccine, so it is not appropriate for everyone. International guidance lists important contraindications including infants younger than 6 months; severe allergy to a vaccine component; symptomatic HIV infection or CD4 count below 200 cells/mm³; significant primary immunodeficiency; transplantation; malignant disease associated with immunosuppression; significant immunosuppressive or immunomodulatory therapy; and thymus disorders associated with abnormal immune function. Other situations require an individual risk-benefit assessment rather than an automatic decision. These include age 6–8 months, age 60 years or older, pregnancy, breastfeeding and asymptomatic HIV infection with moderate immunosuppression. Indian authorised vaccination centres may apply additional eligibility criteria. The Government of India portal specifically advises assessment in pregnancy, breastfeeding, older age, significant comorbidities and several other medical conditions, with the final vaccination decision resting with the nodal officer following risk assessment. Travellers with significant medical conditions should therefore Seek advice from